Influence of allergen-specific immunotherapy on IL-4 receptor alpha-chain expression on monocytes in grass pollen allergy

被引：0
作者：
Grzela, T
Grzela, K
Korczak-Kowalska, G
Zawadzka-Krajewska, A
Lazarczyk, M
机构：
[1] Warsaw Acad Med & Hosp, Dept Histol & Embriol, Warsaw, Poland
[2] Warsaw Acad Med & Hosp, Clin Pulmonol Allergol & Hematol, Warsaw, Poland
[3] Warsaw Acad Med & Hosp, Dept Clin Immunol, Warsaw, Poland
来源：
ALLERGY | 2002年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [41] Is immunotherapy-induced birch-pollen-specific IgG4 a marker for decreased allergen-specific sensitivity?
    Bodtger, U
    Ejrnaes, AM
    Hummelshoj, L
    Jacobi, HH
    Poulsen, LK
    Svenson, M
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2005, 136 (04) : 340 - 346
  • [42] Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. II. Side-effects
    Winther, L
    Malling, HJ
    Mosbech, H
    [J]. ALLERGY, 2000, 55 (09) : 827 - 835
  • [43] IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor alpha chain
    Wang, HY
    Paul, WE
    Keegan, AD
    [J]. IMMUNITY, 1996, 4 (02) : 113 - 121
  • [44] THE EFFECTS OF IL-12 ON THE PRODUCTION OF IL-4 BY HUMAN ALLERGEN-SPECIFIC MEMORY CD4+ T-CELLS
    MARSHALL, JD
    WOLF, SF
    UMETSU, DT
    [J]. FASEB JOURNAL, 1994, 8 (05) : A1004 - A1004
  • [45] Immunotherapy with the recombinant B cell epitope-based grass pollen allergy vaccine BM32 induces a biphasic allergen-specific IgG1 and IgG4 response
    Focke-Tejkl, M.
    Weber, M.
    Flicker, S.
    Zieglmayer, P.
    Schmutz, R.
    Zieglmayer, R.
    Lemell, P.
    Horak, F.
    Neubauer, A.
    Stolz, F.
    Huber, H.
    Henning, R.
    Valenta, R.
    [J]. ALLERGY, 2018, 73 : 778 - 778
  • [46] Quantitative measurement of allergen-specific IgG1 and IgG4 during immunotherapy with the recombinant B cell epitope-based grass pollen allergy vaccine BM32
    Focke-Tejkl, M.
    Weber, M.
    Flicker, S.
    Zieglmayer, P.
    Zieglmayer, R.
    Lemell, P.
    Horak, F.
    Neubauer, A.
    Stolz, F.
    Huber, H.
    Henning, R.
    Valenta, R.
    [J]. ALLERGY, 2017, 72 : 764 - 765
  • [47] Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG4 response
    Eckl-Dorna, Julia
    Wber, Milena
    Stanek, Victoria
    Linhart, Birgit
    Ristl, Robin
    Waltl, Eva E.
    Villazala-Merino, Sergio
    Hummel, Andrea
    Focke-Tejkl, Margarete
    Froeschel, Renate
    Neubauer, Angela
    Henning, Rainer
    Perkmann, Thomas
    Valenta, Rudolf
    Niederberger, Verena
    [J]. EBIOMEDICINE, 2019, 50 : 421 - 432
  • [48] Investigation of clinical efficacy and influence of ribosomal immunotherapy on plasma levels of cytokines IL-4, IL-5, IL-12, IFN-γ, and total IgE in grass-pollen allergy patients during pollen-season
    Bystron, J
    Hermanova, Z
    Szotkovska, J
    Pazderová, D
    [J]. ALLERGY, 2002, 57 : 66 - 66
  • [49] Grass pollen immunotherapy inhibits late phase skin responses and down-regulates IL-4 messenger RNA expression.
    Nouri-Aria, KT
    Varga, EM
    Noble, W
    O'Brien, F
    Walker, SM
    Hamidl, Q
    Durham, SR
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S49 - S49
  • [50] INTERLEUKIN (IL)-12 INHIBITS THE PRODUCTION OF IL-4 AND IL-10 IN ALLERGEN-SPECIFIC HUMAN CD4(+) T-LYMPHOCYTES
    MARSHALL, JD
    SECRIST, H
    DEKRUYFF, RH
    WOLF, SF
    UMETSU, DT
    [J]. FASEB JOURNAL, 1995, 9 (03) : A204 - A204
12345